Paykel-backed NZ serum exporter snaps up Aussie rival

Paykel-backed NZ serum exporter snaps up Aussie rival
Acquiring CellSera adds a 'critical new serum' to the Auckland firm’s existing product range. (Photo: supplied)
Dan Brunskill
Animal serum and plasma exporter Auckland BioSciences (ABS) has purchased an Australian competitor as it seeks to become a global industry leader.The company manufactures and exports premium New Zealand-made animal-derived serum and plasma, which are key ingredients for growing cells for bio-pharmaceutical manufacturing and medical research. While it’s not a glamourous export, this serum is vital to biotech research and the production of vaccines – including some for covid-19.“While our business is operationally complex,...

More Markets

NZ sharemarket up on economic recovery news
Markets Market close

NZ sharemarket up on economic recovery news

The S&P/NZX 50 Index closed at 12,884.38, up 57.05 points or 0.44%.

Graham Skellern 14 Jan 2025
Scott Tech lands $18m in meat processing deals
Primary Sector

Scott Tech lands $18m in meat processing deals

The contracts will be recognised across Scott’s 2025 and 2026 financial years.

Ben Moore 14 Jan 2025
Star on a losing streak, but what about SkyCity?
Retail

Star on a losing streak, but what about SkyCity?

Australasian casinos are disproving the idea that the house always wins.

Dileepa Fonseka 14 Jan 2025
NZ sharemarket starts week down 0.5%
Markets Market close

NZ sharemarket starts week down 0.5%

The S&P/NZX 50 Index closed at 12,827.33, down 68.65 points or 0.53%.

Graham Skellern 13 Jan 2025